RxDoctor Payments DataLook up a doctor →

Arnold del Pilar, DO

Geriatric Medicine · Mishawaka, INNPI 1689675654

Payments from drug & device makers

$84,314in general payments, 2019–2025

Across 1,560 payments — averaging $54.05 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Sumitomo Pharma America, Inc.$23K
  • Astute Medical, Inc.$21K
  • Modernatx, Inc.$16K
  • AbbVie$3K
  • AstraZeneca$3K
  • Amgen$2K
  • plus $17K from 54 others

What the payments were for

  • Food & beverage$24,83898%
  • Education$4392%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Sumitomo Pharma America, Inc.20$22,533
Astute Medical, Inc.17$21,262
Modernatx, Inc.6$15,500
AbbVie(2 entities)245$3,193
AstraZeneca116$2,700
Amgen97$2,353
Novo Nordisk137$1,513
GSK118$1,335
Boehringer Ingelheim91$1,303
Lilly USA, LLC81$1,261
Teva Pharmaceuticals USA, Inc.63$1,083
Pfizer51$792
Sanofi-aventis U.S. LLC45$719
Bayer34$709
Sunovion Pharmaceuticals Inc.52$646
Grifols USA, LLC27$567
Esperion Therapeutics, Inc.25$550
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)28$498
Astellas Pharma US Inc12$480
Vanda Pharmaceuticals Inc.14$443
Insulet Corporation35$411
Mylan Specialty L.p.22$406
Otsuka America Pharmaceutical, Inc.18$373
Johnson & Johnson26$352
Novartis25$330
Neurocrine Biosciences, Inc.14$265
Biohaven Pharmaceutical Holding Company Ltd.10$218
Biohaven Pharmaceuticals, Inc.8$204
Axsome Therapeutics, Inc.10$193
Redhill Biopharma Inc.7$148
Aimmune Therapeutics, Inc.4$140
Amarin Pharma, Inc.7$140
Takeda Pharmaceuticals U.S.A., Inc.8$129
Lundbeck LLC7$127
Paratek Pharmaceuticals, Inc.6$114
Abbott6$112
Lupin Inc.6$93
Dexcom, Inc.6$91
Supernus Pharmaceuticals, Inc.6$90
Arbor Pharmaceuticals, Inc.3$86
Ardelyx, Inc.3$61
Ironwood Pharmaceuticals, Inc5$60
VBI Vaccine (delaware) Inc.2$58
Fidia Pharma USA Inc.3$58
Merck4$57
Currax Pharmaceuticals LLC3$52
Nestle Healthcare Nutrition Inc.1$50
Radius Health, Inc.3$44
Nabriva Therapeutics, PLC3$44
Hologic Sales And Service, LLC2$43
Corcept Therapeutics2$42
Genentech USA, Inc.2$35
Shire North American Group Inc2$35
Sanofi Pasteur Inc.1$26
Organogenesis Inc.1$23
Biomerieux Inc1$23
Viatris Specialty LLC1$19
Seqirus USA Inc1$17
Adlon Therapeutics L.p.1$17
Avanir Pharmaceuticals, Inc.1$17

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$84,314 in reported general payments places this provider in the 95th percentile of 70 geriatric medicine providers in Indiana.

See all geriatric medicine providers in Indiana

Medicare billing

Part B allowed, 2024
$160,816
Medicare patients
142
Services billed
3,234

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide84$118,826
Trelegy ElliptaFluticasone/Umeclidin/Vilanter153$102,743
MounjaroTirzepatide67$75,506
JardianceEmpagliflozin45$72,158
EliquisApixaban64$71,080
CreonLipase/Protease/Amylase18$58,443
FarxigaDapagliflozin Propanediol39$44,715
Repatha SureclickEvolocumab53$38,096
LinzessLinaclotide35$35,257
XareltoRivaroxaban23$28,372
KerendiaFinerenone23$27,459
TrulicityDulaglutide24$22,589
Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog19$22,000
Tresiba Flextouch U-100Insulin Degludec18$16,829
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr16$14,811

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$1,513$118,82684 claims
GSKTrelegy Ellipta, Anoro Ellipta$1,335$117,554169 claims
AbbVieCreon, Linzess, Armour Thyroid, Synthroid$3,193$100,825160 claims
Lilly USA, LLCMounjaro, Trulicity$1,261$98,09591 claims
Boehringer IngelheimJardiance$1,303$72,15845 claims
PfizerEliquis$792$71,08064 claims
AstraZenecaFarxiga, Breztri Aerosphere$2,700$54,79155 claims
Johnson & JohnsonXarelto$352$28,37223 claims
BayerKerendia$709$27,45923 claims
NovartisEntresto$330$10,74114 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 70 geriatric medicine providers in Indiana.

Other geriatric medicine in Mishawaka

See the full list for Indiana

Where these figures come from

Is this you, or does something look wrong? →